1. Home
  2. MYSZ vs ARTL Comparison

MYSZ vs ARTL Comparison

Compare MYSZ & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo My Size Inc.

MYSZ

My Size Inc.

HOLD

Current Price

$1.56

Market Cap

2.2M

Sector

Technology

ML Signal

HOLD

ARTL

Artelo Biosciences Inc.

N/A

Current Price

$3.55

Market Cap

2.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYSZ
ARTL
Founded
1999
2011
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.5M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
MYSZ
ARTL
Price
$1.56
$3.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
708.3K
★ 1.3M
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.40
N/A
EPS
N/A
★ N/A
Revenue
★ $142,000.00
N/A
Revenue This Year
$38.86
N/A
Revenue Next Year
$9.69
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 125.40
N/A
52 Week Low
$0.33
$0.52
52 Week High
$4.28
$19.91

Technical Indicators

Market Signals
Indicator
MYSZ
ARTL
Relative Strength Index (RSI) 43.94 46.09
Support Level $0.47 $3.20
Resistance Level $2.60 $6.81
Average True Range (ATR) 0.16 1.25
MACD -0.05 -0.30
Stochastic Oscillator 5.52 0.49

Price Performance

Historical Comparison
MYSZ
ARTL

About MYSZ My Size Inc.

My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: